SOL Director Dealings Neutral

SASOL LIMITED - Dealings In Securities By Directors And Prescribed Officers Of Sasol Limited And Directors Of Major Subsidiaries Of Sasol Limited

Sasol Limited
Full analysis

What this filing means

Sasol has disclosed the vesting and sale of 2021 long-term incentive awards by nine directors and prescribed officers on 28 September 2026. The transactions are the mechanical completion of a scheme cycle: the second and final tranche of the 2021 award vested at the achievement of corporate performance targets set for the period ending in 2024, and participants either retained shares or sold to cover tax. The largest sale was V D Kahla's combined ZAR 5.01 million across two tranches. This is administrative disclosure, not a fresh signal about Sasol's prospects.

Sasol's directors and senior executives received shares they were promised back in 2021 as part of their long-term pay. Some kept the shares, some sold just enough to pay the tax bill. This is a standard, scheduled event that happens every year when these awards mature — it tells you the scheme is working as designed, but it says nothing new about how the company is performing now.

Bear case

  • The filing does not disclose whether any sales beyond tax coverage were made for personal liquidity reasons.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

A routine director-dealings filing with no economic signal. The vesting of the 2021 LTI award and the subsequent retention or tax-covering sales are the mechanical completion of a compensation cycle, not a fresh view on Sasol's value. So what: nothing here changes the investment case; the market still needs the next operational or financial update to move on fundamentals.

The next results or trading statement is where the market will test whether the operational momentum behind the recent share-price strength is sustained.

Evidence from the filing

  • Verbatim anchor from the filing, retained so this analysis stays checkable against the source.

    “4. In terms of the MSR policy, directors and prescribed officers may sell vested shares to cover the taxation and transaction cost on the vested LTI award.”
Category
Director Dealings
Event posture
No Edge
Published
Sep 30, 2026

More on Sasol Limited

Related filings